T. Rowe Price Health Sciences Fund, Inc.
About this Fund
T. Rowe Price Health Sciences Fund, Inc. is a renowned mutual fund company that specializes in providing a diverse range of investment solutions to individual and institutional investors, with a strong focus on wealth management and asset management. As a trusted name in the industry, the company offers a variety of mutual funds that cater to different investment objectives and risk tolerance levels, including equity, debt, and hybrid funds. For investors seeking to capitalize on the growth potential of the healthcare sector, the T. Rowe Price Health Sciences Fund is a compelling option, leveraging the expertise of seasoned investment professionals to navigate the complexities of the health sciences industry. By adopting a disciplined and research-driven approach to investment, the company aims to deliver long-term returns that meet or exceed the expectations of its investors, while also providing a high level of transparency and accountability. The company's investment philosophy is centered on a deep understanding of the markets and a commitment to rigorous research, which enables its team of experienced portfolio managers to identify attractive investment opportunities and construct well-diversified portfolios that balance risk and potential return. For investors who prefer a systematic and disciplined approach to investing, the company offers a systematic investment plan, or SIP, which allows them to invest a fixed amount of money at regular intervals, regardless of market conditions. This approach can help reduce timing risks and promote a long-term perspective, which is essential for achieving investment success. With a strong track record of performance and a reputation for integrity and trust, T. Rowe Price Health Sciences Fund, Inc. has established itself as a trusted partner for investors seeking to grow their wealth over the long term, and its mutual funds are widely recognized as a key component of a well-diversified investment portfolio. The company's investor-focused approach is designed to provide a high level of service and support, with a dedicated team of investment professionals available to provide guidance and assistance to investors at every stage of the investment process. By prioritizing the needs and goals of its investors, T. Rowe Price Health Sciences Fund, Inc. has built a loyal client base and established itself as a leader in the mutual fund industry, with a strong reputation for delivering exceptional investment results and outstanding client service. As a specialist in asset management and wealth management, the company is well-positioned to help investors achieve their financial goals, whether they are seeking to grow their wealth, generate income, or preserve their capital. With its expertise, experience, and commitment to excellence, T. Rowe Price Health Sciences Fund, Inc. is an ideal choice for investors seeking a trusted and reliable partner to help them navigate the complexities of the investment landscape.
Holdings
From latest SEC N-PORT filing · US-listed stocks only
| # | Security Name | CUSIP | Asset Type | Weight % | Value ($M) | Quantity |
|---|---|---|---|---|---|---|
| 1 | ABBV ABBVIE INC Since 2026-05-10 | 00287Y109 | Equity (Common) |
2.75%
|
$332.37 | 1,454,646 |
| 2 | AGIO AGIOS PHARMACEUTICALS INC Since 2026-05-10 | 00847X104 | Equity (Common) |
0.08%
|
$9.42 | 346,220 |
| 3 | ALHC ALIGNMENT HEALTHCARE INC Since 2026-05-10 | 01625V104 | Equity (Common) |
0.23%
|
$27.70 | 1,402,808 |
| 4 | ALKS ALKERMES PLC Since 2026-05-10 | — | Equity (Common) |
0.06%
|
$7.82 | 279,307 |
| 5 | ALLO ALLOGENE THERAPEUTICS INC Since 2026-05-10 | 019770106 | Equity (Common) |
0.02%
|
$2.94 | 2,147,980 |
| 6 | ALNY ALNYLAM PHARMACEUTICALS INC Since 2026-05-10 | 02043Q107 | Equity (Common) |
2.27%
|
$274.61 | 690,581 |
| 7 | ANNX ANNEXON INC Since 2026-05-10 | 03589W102 | Equity (Common) |
0.01%
|
$1.02 | 204,248 |
| 8 | APGE APOGEE THERAPEUTICS INC Since 2026-05-10 | 03770N101 | Equity (Common) |
0.40%
|
$48.15 | 637,936 |
| 9 | ACLX ARCELLX INC Since 2026-05-10 | 03940C100 | Equity (Common) |
0.21%
|
$24.91 | 381,990 |
| 10 | ARQT ARCUTIS BIOTHERAPEUTICS INC Since 2026-05-10 | 03969K108 | Equity (Common) |
0.13%
|
$16.27 | 560,191 |
| 11 | ARWR ARROWHEAD PHARMACEUTICALS INC Since 2026-05-10 | 04280A100 | Equity (Common) |
0.19%
|
$22.44 | 338,015 |
| 12 | AURA AURA BIOSCIENCES INC Since 2026-05-10 | 05153U107 | Equity (Common) |
0.01%
|
$1.39 | 255,721 |
| 13 | AXSM AXSOME THERAPEUTICS INC Since 2026-05-10 | 05464T104 | Equity (Common) |
0.38%
|
$45.38 | 248,476 |
| 14 | BEAM BEAM THERAPEUTICS INC Since 2026-05-10 | 07373V105 | Equity (Common) |
0.25%
|
$30.54 | 1,101,691 |
| 15 | BBNX BETA BIONICS INC Since 2026-05-10 | 08659B102 | Equity (Common) |
0.10%
|
$12.06 | 395,769 |
| 16 | BCAX BICARA THERAPEUTICS INC Since 2026-05-10 | 055477103 | Equity (Common) |
0.12%
|
$13.91 | 826,367 |
| 17 | BHVN BIOHAVEN LTD Since 2026-05-10 | — | Equity (Common) |
0.07%
|
$8.76 | 775,801 |
| 18 | BBOT BridgeBio Oncology Therapeutics Inc Since 2026-05-10 | 107924102 | Equity (Common) |
0.06%
|
$7.80 | 623,141 |
| 19 | BBIO BRIDGEBIO PHARMA INC Since 2026-05-10 | 10806X102 | Equity (Common) |
0.55%
|
$66.25 | 866,177 |
| 20 | CABA CABALETTA BIO INC Since 2026-05-10 | 12674W109 | Equity (Common) |
0.02%
|
$2.04 | 931,483 |
| 21 | CAH CARDINAL HEALTH INC Since 2026-05-10 | 14149Y108 | Equity (Common) |
0.56%
|
$67.23 | 327,179 |
| 22 | CAI CARIS LIFE SCIENCES INC Since 2026-05-10 | 142152107 | Equity (Common) |
0.43%
|
$51.72 | 1,916,953 |
| 23 | CELC CELCUITY INC Since 2026-05-10 | 15102K100 | Equity (Common) |
0.48%
|
$57.43 | 575,794 |
| 24 | CLDX CELLDEX THERAPEUTICS INC Since 2026-05-10 | 15117B202 | Equity (Common) |
0.08%
|
$9.76 | 359,422 |
| 25 | COR CENCORA INC Since 2026-05-10 | 03073E105 | Equity (Common) |
0.60%
|
$72.81 | 215,573 |
| 26 | CGON CG ONCOLOGY INC Since 2026-05-10 | 156944100 | Equity (Common) |
0.34%
|
$41.57 | 1,001,152 |
| 27 | CLYM Climb Bio Inc Since 2026-05-10 | 28658R106 | Equity (Common) |
0.05%
|
$5.98 | 1,494,439 |
| 28 | COGT COGENT BIOSCIENCES INC Since 2026-05-10 | 19240Q201 | Equity (Common) |
0.10%
|
$12.15 | 342,207 |
| 29 | CBIO CRESCENT BIOPHARMA INC Since 2026-05-10 | — | Equity (Common) |
0.03%
|
$3.03 | 255,639 |
| 30 | DNLI DENALI THERAPEUTICS INC Since 2026-05-10 | 24823R105 | Equity (Common) |
0.14%
|
$16.97 | 1,027,763 |
| 31 | DNTH DIANTHUS THERAPEUTICS INC Since 2026-05-10 | 252828108 | Equity (Common) |
0.07%
|
$7.91 | 191,861 |
| 32 | IRON DISC MEDICINE INC Since 2026-05-10 | 254604101 | Equity (Common) |
0.26%
|
$31.34 | 394,643 |
| 33 | TRDA ENTRADA THERAPEUTICS INC Since 2026-05-10 | 29384C108 | Equity (Common) |
0.01%
|
$1.76 | 171,368 |
| 34 | EVMN EVOMMUNE INC Since 2026-05-10 | 30054Y107 | Equity (Common) |
0.04%
|
$4.73 | 276,188 |
| 35 | WGS GENEDX HOLDINGS CORP Since 2026-05-10 | 81663L200 | Equity (Common) |
0.16%
|
$19.05 | 146,500 |
| 36 | GILD GILEAD SCIENCES INC Since 2026-05-10 | 375558103 | Equity (Common) |
2.17%
|
$261.65 | 2,131,780 |
| 37 | DNA GINKGO BIOWORKS HOLDINGS INC Since 2026-05-10 | 37611X209 | Equity (Common) |
0.00%
|
$0.21 | 25,388 |
| 38 | GH GUARDANT HEALTH INC Since 2026-05-10 | 40131M109 | Equity (Common) |
0.93%
|
$112.36 | 1,100,084 |
| 39 | HTFL HEARTFLOW INC Since 2026-05-10 | 42238D107 | Equity (Common) |
0.08%
|
$9.97 | 342,110 |
| 40 | HIMS HIMS & HERS HEALTH INC Since 2026-05-10 | 433000106 | Equity (Common) |
0.03%
|
$3.42 | 105,203 |
| 41 | IDYA IDEAYA BIOSCIENCES INC Since 2026-05-10 | 45166A102 | Equity (Common) |
0.08%
|
$9.15 | 264,685 |
| 42 | IDXX IDEXX LABORATORIES INC Since 2026-05-10 | 45168D104 | Equity (Common) |
0.74%
|
$89.94 | 132,942 |
| 43 | IMNM IMMUNOME INC Since 2026-05-10 | 45257U108 | Equity (Common) |
0.39%
|
$46.63 | 2,171,072 |
| 44 | IMVT IMMUNOVANT INC Since 2026-05-10 | 45258J102 | Equity (Common) |
0.11%
|
$13.22 | 520,122 |
| 45 | INSP INSPIRE MEDICAL SYSTEMS INC Since 2026-05-10 | 457730109 | Equity (Common) |
0.11%
|
$13.30 | 144,206 |
| 46 | ISRG INTUITIVE SURGICAL INC Since 2026-05-10 | 46120E602 | Equity (Common) |
4.48%
|
$541.00 | 955,225 |
| 47 | IONS IONIS PHARMACEUTICALS INC Since 2026-05-10 | 462222100 | Equity (Common) |
0.67%
|
$80.67 | 1,019,711 |
| 48 | IOVA IOVANCE BIOTHERAPEUTICS INC Since 2026-05-10 | 462260100 | Equity (Common) |
0.01%
|
$1.57 | 575,611 |
| 49 | IQV IQVIA HOLDINGS INC Since 2026-05-10 | 46266C105 | Equity (Common) |
0.31%
|
$37.87 | 168,007 |
| 50 | JANX JANUX THERAPEUTICS INC Since 2026-05-10 | 47103J105 | Equity (Common) |
0.01%
|
$1.01 | 72,899 |
| 51 | KMTS KESTRA MEDICAL TECHNOLOGIES Since 2026-05-10 | — | Equity (Common) |
0.18%
|
$21.27 | 801,852 |
| 52 | KOD KODIAK SCIENCES INC Since 2026-05-10 | 50015M109 | Equity (Common) |
0.17%
|
$20.29 | 725,750 |
| 53 | KRYS KRYSTAL BIOTECH INC Since 2026-05-10 | 501147102 | Equity (Common) |
0.65%
|
$78.42 | 318,084 |
| 54 | KYMR KYMERA THERAPEUTICS INC Since 2026-05-10 | 501575104 | Equity (Common) |
0.80%
|
$96.03 | 1,234,213 |
| 55 | KYTX KYVERNA THERAPEUTICS INC Since 2026-05-10 | 501976104 | Equity (Common) |
0.10%
|
$12.41 | 1,320,654 |
| 56 | LENZ LENZ THERAPEUTICS INC Since 2026-05-10 | 52635N103 | Equity (Common) |
0.02%
|
$2.73 | 170,941 |
| 57 | MDGL MADRIGAL PHARMACEUTICALS INC Since 2026-05-10 | 558868105 | Equity (Common) |
0.30%
|
$36.12 | 62,028 |
| 58 | MBX MBX BIOSCIENCES INC Since 2026-05-10 | 55287L101 | Equity (Common) |
0.16%
|
$19.42 | 615,715 |
| 59 | MDWD MEDIWOUND LTD Since 2026-05-10 | — | Equity (Common) |
0.02%
|
$2.52 | 136,760 |
| 60 | MRK MERCK & CO. INC. Since 2026-05-10 | 58933Y105 | Equity (Common) |
1.82%
|
$219.28 | 2,083,252 |
| 61 | MIRM MIRUM PHARMACEUTICALS INC Since 2026-05-10 | 604749101 | Equity (Common) |
0.09%
|
$11.13 | 140,915 |
| 62 | MOH MOLINA HEALTHCARE INC Since 2026-05-10 | 60855R100 | Equity (Common) |
0.13%
|
$16.01 | 92,264 |
| 63 | GLUE MONTE ROSA THERAPEUTICS INC Since 2026-05-10 | 61225M102 | Equity (Common) |
0.15%
|
$18.60 | 1,186,156 |
| 64 | MLTX MOONLAKE IMMUNOTHERAPEUTICS Since 2026-05-10 | 61559X104 | Equity (Common) |
0.08%
|
$9.78 | 742,022 |
| 65 | NTRA NATERA INC Since 2026-05-10 | 632307104 | Equity (Common) |
1.07%
|
$129.85 | 566,806 |
| 66 | NBIX NEUROCRINE BIOSCIENCES INC Since 2026-05-10 | 64125C109 | Equity (Common) |
0.26%
|
$31.62 | 222,974 |
| 67 | NRIX NURIX THERAPEUTICS INC Since 2026-05-10 | 67080M103 | Equity (Common) |
0.21%
|
$25.87 | 1,363,852 |
| 68 | NUVB NUVATION BIO INC Since 2026-05-10 | 67080N101 | Equity (Common) |
0.14%
|
$16.93 | 1,889,484 |
| 69 | OLMA OLEMA PHARMACEUTICALS INC Since 2026-05-10 | 68062P106 | Equity (Common) |
0.17%
|
$20.63 | 825,139 |
| 70 | OBIO ORCHESTRA BIOMED HOLDINGS INC Since 2026-05-10 | 68572M106 | Equity (Common) |
0.01%
|
$1.07 | 258,756 |
| 71 | ORIC ORIC PHARMACEUTICALS INC Since 2026-05-10 | 68622P109 | Equity (Common) |
0.06%
|
$7.69 | 940,154 |
| 72 | ORKA ORUKA THERAPEUTICS INC Since 2026-05-10 | 687604108 | Equity (Common) |
0.12%
|
$14.03 | 462,775 |
| 73 | PALI PALISADE BIO INC Since 2026-05-10 | 696389402 | Equity (Common) |
0.02%
|
$2.92 | 1,241,126 |
| 74 | PEN PENUMBRA INC Since 2026-05-10 | 70975L107 | Equity (Common) |
1.38%
|
$166.68 | 536,111 |
| 75 | PTGX PROTAGONIST THERAPEUTICS INC Since 2026-05-10 | 74366E102 | Equity (Common) |
0.69%
|
$83.43 | 955,194 |
| 76 | RDNT RADNET INC Since 2026-05-10 | 750491102 | Equity (Common) |
0.10%
|
$12.21 | 171,203 |
| 77 | RAPP RAPPORT THERAPEUTICS INC Since 2026-05-10 | 75383L102 | Equity (Common) |
0.16%
|
$19.52 | 643,434 |
| 78 | REGN REGENERON PHARMACEUTICALS Since 2026-05-10 | 75886F107 | Equity (Common) |
2.55%
|
$308.14 | 399,214 |
| 79 | RLAY RELAY THERAPEUTICS INC Since 2026-05-10 | 75943R102 | Equity (Common) |
0.08%
|
$9.35 | 1,104,939 |
| 80 | REPL REPLIMUNE GROUP INC Since 2026-05-10 | 76029N106 | Equity (Common) |
0.12%
|
$14.30 | 1,470,920 |
| 81 | RVMD REVOLUTION MEDICINES INC Since 2026-05-10 | 76155X100 | Equity (Common) |
0.94%
|
$114.05 | 1,431,908 |
| 82 | RVTY REVVITY INC Since 2026-05-10 | 714046109 | Equity (Common) |
0.24%
|
$28.58 | 295,443 |
| 83 | RYTM RHYTHM PHARMACEUTICALS INC Since 2026-05-10 | 76243J105 | Equity (Common) |
0.27%
|
$33.11 | 309,295 |
| 84 | RCKT ROCKET PHARMACEUTICALS INC Since 2026-05-10 | 77313F106 | Equity (Common) |
0.02%
|
$1.89 | 537,262 |
| 85 | ROIV ROIVANT SCIENCES LTD Since 2026-05-10 | — | Equity (Common) |
0.60%
|
$71.94 | 3,315,138 |
| 86 | SANA SANA BIOTECHNOLOGY INC Since 2026-05-10 | 799566104 | Equity (Common) |
0.02%
|
$1.88 | 462,536 |
| 87 | STTK SHATTUCK LABS INC Since 2026-05-10 | 82024L103 | Equity (Common) |
0.04%
|
$5.43 | 1,488,397 |
| 88 | SION SIONNA THERAPEUTICS INC Since 2026-05-10 | 829401108 | Equity (Common) |
0.22%
|
$26.04 | 633,011 |
| 89 | SLNO SOLENO THERAPEUTICS INC Since 2026-05-10 | 834203309 | Equity (Common) |
0.04%
|
$5.20 | 112,291 |
| 90 | SYRE Spyre Therapeutics Inc Since 2026-05-10 | 00773J202 | Equity (Common) |
0.24%
|
$29.37 | 896,465 |
| 91 | SMMT SUMMIT THERAPEUTICS INC Since 2026-05-10 | 86627T108 | Equity (Common) |
1.05%
|
$127.44 | 7,286,202 |
| 92 | TARS TARSUS PHARMACEUTICALS INC Since 2026-05-10 | 87650L103 | Equity (Common) |
0.25%
|
$30.64 | 374,184 |
| 93 | TERN TERNS PHARMACEUTICALS INC Since 2026-05-10 | 880881107 | Equity (Common) |
0.16%
|
$19.29 | 477,405 |
| 94 | TMO THERMO FISHER SCIENTIFIC INC Since 2026-05-10 | 883556102 | Equity (Common) |
4.27%
|
$516.02 | 890,534 |
| 95 | RARE ULTRAGENYX PHARMACEUTICAL INC Since 2026-05-10 | 90400D108 | Equity (Common) |
0.09%
|
$10.41 | 452,583 |
| 96 | URGN UROGEN PHARMA LTD Since 2026-05-10 | — | Equity (Common) |
0.09%
|
$10.75 | 459,055 |
| 97 | PCVX VAXCYTE INC Since 2026-05-10 | 92243G108 | Equity (Common) |
0.17%
|
$21.01 | 455,345 |
| 98 | VERA VERA THERAPEUTICS INC Since 2026-05-10 | 92337R101 | Equity (Common) |
0.83%
|
$99.69 | 1,968,700 |
| 99 | VRDN VIRIDIAN THERAPEUTICS INC Since 2026-05-10 | 92790C104 | Equity (Common) |
0.16%
|
$19.62 | 630,615 |
| 100 | VYGR VOYAGER THERAPEUTICS INC Since 2026-05-10 | 92915B106 | Equity (Common) |
0.01%
|
$1.07 | 273,538 |
| 101 | WVE WAVE LIFE SCIENCES LTD Since 2026-05-10 | — | Equity (Common) |
0.22%
|
$26.00 | 1,529,350 |
| 102 | XNCR XENCOR INC Since 2026-05-10 | 98401F105 | Equity (Common) |
0.06%
|
$6.70 | 437,762 |
| 103 | XENE XENON PHARMACEUTICALS INC Since 2026-05-10 | 98420N105 | Equity (Common) |
0.04%
|
$5.41 | 120,751 |
| 104 | ZTS ZOETIS INC Since 2026-05-10 | 98978V103 | Equity (Common) |
0.15%
|
$18.63 | 148,079 |